Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma ; volume:17 ; number:1 ; day:24 ; month:2 ; year:2017 ; pages:1-23 ; date:12.2017
BMC cancer ; 17, Heft 1 (24.2.2017), 1-23, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Bayat Mokhtari, Reza
- Beteiligte Personen und Organisationen
-
Baluch, Narges
Ka Hon Tsui, Micky
Kumar, Sushil
S. Homayouni, Tina
Aitken, Karen
Das, Bikul
Baruchel, Sylvain
Yeger, Herman
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3126-7
- URN
-
urn:nbn:de:1111-201703183589
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bayat Mokhtari, Reza
- Baluch, Narges
- Ka Hon Tsui, Micky
- Kumar, Sushil
- S. Homayouni, Tina
- Aitken, Karen
- Das, Bikul
- Baruchel, Sylvain
- Yeger, Herman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming
Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer
In vivo silencing of A20 via TLR9-mediated targeted siRNA delivery potentiates anti-tumor immune response
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
Zebularine potentiates anti-tumor immunity by inducing tumor immunogenicity and improving antigen processing through cGAS-STING pathway
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming
Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer
In vivo silencing of A20 via TLR9-mediated targeted siRNA delivery potentiates anti-tumor immune response
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
Zebularine potentiates anti-tumor immunity by inducing tumor immunogenicity and improving antigen processing through cGAS-STING pathway
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming
Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer
In vivo silencing of A20 via TLR9-mediated targeted siRNA delivery potentiates anti-tumor immune response
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
Zebularine potentiates anti-tumor immunity by inducing tumor immunogenicity and improving antigen processing through cGAS-STING pathway